Document is current
Any future updates will be listed below
-
Authors
Tablado Alonso, Sara
Inocêncio Da Luz, Raquel
Van Reet, Nick
Ngay, Ipos
Pemba, Marguerite Manwana
Rogé, Stijn
Kwete, Jean
Nicco, Elena
Rigouts, Leen
Miaka, Erick Mwamba
Ngoyi, Dieudonné Mumba
Verlé, Paul
Büscher, Philippe
Hasker, Epco
-
Funding
Funding for this research was provided by:
Belgian Directorate General for Development Cooperation and Humanitarian Aid through the 5th Framework Agreement
- License Information
-
More Information
Article History
Received: 11 June 2025
Accepted: 28 November 2025
First Online: 6 December 2025
Declarations
:
: This study received ethical clearance from ITM’s Institutional Review Board (reference 1590/22), from the Ethics Committee of the University of Antwerp, Belgium (Belgian registration number B3002022000077) and from the Ethics Committee of the Université Protestante au Congo (Reference CEUPC 0101). Written informed consent was obtained from all study participants. For minors, assent was obtained and parents or legal guardians provided written informed consent. Individuals who attended the screening campaign but did not wish to take part in the study were tested and, if needed, treated following the guidelines of the Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA) of the RDC. The study was registered at clinicaltrials.gov under the identifier NCT05637632.
: Not applicable.
: The Institute of Tropical Medicine, in Antwerp (Belgium), where STA, RIL, NVR, SR, EN, PV, PB and EH work, is the producer of the Card Agglutination Test for Trypanosomiasis (CATT). All the other authors have no competing interests.
